No credit card, no obligation Financial Professionals only
Already a Horsesmouth member?
Biotechs remain an area of leadership, albeit an unusually risky one, and market internals still don’t appear to be strong enough to support a move to a decisive new high.
The biotech field is famous for the uncertainty of its companies' and products' success. Coming off its most actively traded year since 2000, clearly many are comfortable with the risk.
IMPORTANT NOTICE This material is provided exclusively for use by Horsesmouth members and is subject to Horsesmouth Terms & Conditions and applicable copyright laws. Unauthorized use, reproduction or distribution of this material is a violation of federal law and punishable by civil and criminal penalty. This material is furnished “as is” without warranty of any kind. Its accuracy and completeness is not guaranteed and all warranties express or implied are hereby excluded.
Social Security and Medicare Workshop
With Elaine Floyd, CFP®
May 12–15, 2025
The Discovery Meeting Workshop: Transform Your Discovery Process
May 19–20, 2025